Log in or Sign up for Free to view tailored content for your specialty!
Depression News
DEA grants Schedule I license for psilocybin treatment, MDD clinical trial to begin
Biopharmaceutical company Cybin Inc. and its partner Clinilabs Drug Development Corp. announced they have been granted a Schedule I license to support a clinical trial for a psychedelic-based treatment to treat major depressive disorder.
Higher dose of omega-3 fatty acid reduced MDD in overweight adults at 12 weeks
Eicosapentaenoic acid at a dose of 4 g per day reduced effects of major depressive disorder in overweight individuals with elevated inflammatory markers better than placebo at 12 weeks, according to a recently published study.
Log in or Sign up for Free to view tailored content for your specialty!
APA: U.S. adults support mental health initiatives in schools, gun violence a top concern
A majority of adults in the United States agreed on the importance of schools playing a key role in advocating for mental health, according to results of a recent survey from the American Psychiatric Association.
Poll: Medicare customers say plans need more mental health, substance abuse coverage
According to a recent poll, overall customer satisfaction with Medicare Advantage plans has increased, yet a majority of plan members say they do not have enough coverage for mental health and substance use disorder services.
Family history of psychiatric disorder nearly doubles postpartum depression risk
Women who had a family history of any psychiatric disorder were almost twice as likely to experience postpartum depression compared with women who had no history, according to a meta-analysis published in JAMA Psychiatry.
Back to school with digestive disorders: Parent-school partnership key to patient support
School can be a wonderful source of social and academic connection, but for children with chronic digestive conditions and intrusive symptoms, the experience can become significantly more challenging and anxiety-provoking.
Deep brain stimulation shows efficacy for treatment-resistant depression
Deep brain stimulation to the superolateral branch of the medial forebrain bundle was an efficacious therapy for those with treatment-resistant depression, researchers reported in Molecular Psychiatry.
APA: New digital model created to address psychiatric bed crisis in the U.S.
The American Psychiatric Association has issued a report detailing a strategy for addressing the crisis of psychiatric bed availability and need.
HHS awards University of Tennessee grant to provide mental health care to rural areas
The University of Tennessee’s College of Nursing has been awarded a $3.7 million grant from HHS to provide mental health care services to rural communities with underrepresented and minority populations.
Survey says mental health chief concern for college students as school year begins
According to a recent survey, 49% of college students reported that mental health is their top concern as the fall semester begins, topping a list that included academics, inflation and mass shootings.
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read
-
Headline News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
November 11, 20246 min read -
Headline News
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
November 11, 20243 min read -
Headline News
Culture shift needed to reframe cybersecurity as a patient safety issue
November 11, 202410 min read